Neil Gregory Almstead sold $1.9M of Ptc Therapeutics, Inc. (PTCT) stock

Neil Gregory Almstead, Chief Technical Ops Officer of Ptc Therapeutics, Inc. (PTCT), sold 23,749 shares of PTCT stock worth $1.9M, per an SEC Form 4 filed Jun 24, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 22, 2026, 2 days before it was made public.

PTCT has moved -19.4% since the trade date, from $80.96 to $65.26 (Sep 21, 2026 close).